Cover Image

Severe asthma resistant to biological treatment?

Saved in:

Bibliographic Details
Main Authors:	Marta Bascuas Arribas (Author), María Camino Serrano (Author), Verónica Sanz Santiago (Author), Alejandro López-Neyra (Author)
Format:	Book
Published:	Elsevier, 2024-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Biological treatment options for severe asthma in Poland
by: Maciej Superson, et al.
Published: (2024)

Biologic Therapies: Targeting Severe Asthma at the Molecular Level
by: Kamila Szewczyk, et al.
Published: (2024)

Role of biologics in severe eosinophilic asthma – focus on reslizumab
by: Pelaia G, et al.
Published: (2016)

Modeling of the impact of biological drugs in the economic burden of severe asthma
by: S. K. Zyryanov, et al.
Published: (2020)

Allergy immunotherapy in combination with biological therapy in moderate and severe asthma
by: Dariya S. Kulichenko, et al.
Published: (2023)

Utilizing Predictive Inflammatory Markers for Guiding the Use of Biologicals in Severe Asthma
by: Runnstrom M, et al.
Published: (2022)

Overview on the treatment of severe bronchial asthma
by: Giulio Dinardo, et al.
Published: (2024)

Novel treatment of severe eosinophilic asthma
by: article editorial
Published: (2020)

Exploring the Interaction between Fractional Exhaled Nitric Oxide and Biologic Treatment in Severe Asthma: A Systematic Review
by: Tommaso Pianigiani, et al.
Published: (2023)

Biologic Therapies for Moderate to Severe Asthma in the Pediatric Population: A Practice Update
by: Concettina Tolomeo DNP, MBA, APRN, FNP-
Published: (2023)

Omalizumab and mepolizumab in the landscape of biological therapy for severe asthma in children: how to choose?
by: Mattia Giovannini, et al.
Published: (2019)

Biological Treatments and Target Therapies for Pediatric Respiratory Medicine: Not Only Asthma
by: Sergio Ghirardo, et al.
Published: (2022)

Clinical Practice Guidelines for Severe Asthma Treatment.
by: Eddy Pereira Valdes, et al.
Published: (2009)

Clinical Practice Guidelines for Severe Asthma Treatment.
by: Eddy Pereira Valdes, et al.
Published: (2009)

Unconventional Treatment Options in Severe Asthma: An Overivew
by: Hoan Linh Banh
Published: (2011)

Long-term effect of antifungal therapy for the treatment of severe resistant asthma: an active comparator clinical trial
by: Majid Mirsadraee, et al.
Published: (2019)

A retrospective analysis of severe asthma treatment with Mepolizumab
by: Mattia Serao, et al.
Published: (2019)

MONTELUCAST APPLICATION IN TREATMENT FOR BRONCHIAL ASTHMA OF VARIOUS SEVERITY
by: A.V. Kamaev, et al.
Published: (2007)

MONTELUCAST APPLICATION IN TREATMENT FOR BRONCHIAL ASTHMA OF VARIOUS SEVERITY
by: A.V. Kamaev, et al.
Published: (2007)

The effectiveness of the treatment of severe exercise-induced asthma in schoolchildren
by: M.N. Garas, et al.
Published: (2017)

Cost-effectiveness analysis of the use of mepolizumab in omalizumab-resistant patients with severe asthma
by: A. G. Tolkushin, et al.
Published: (2019)

Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation
by: S. K. Zyryanov, et al.
Published: (2020)

Organización y valoración de la atención telefónica urgente hospitalaria pediátrica ante la pandemia COVID-19
by: Jara Gaitero Tristán, et al.
Published: (2021)

Organisation and assessment of urgent paediatric telephonic hospital care during the COVID-19 pandemic
by: Jara Gaitero Tristán, et al.
Published: (2021)

Do not forget asthma comorbidities in pediatric severe asthma!
by: Lucia Ronco, et al.
Published: (2022)

Severe refractory asthma: current treatment options and ongoing research
by: Francesco Menzella, et al.
Published: (2018)

Dupilumab in the Treatment of Moderate to Severe Asthma: An Evidence-Based Review
by: Kiran Kumar Rathinam, PharmD, et al.
Published: (2019)

Treatment Resistance in Severe Asthma Patients With a Combination of High Fraction of Exhaled Nitric Oxide and Low Blood Eosinophil Counts
by: Yuki Hoshino, et al.
Published: (2022)

Difficult and Severe Asthma in Children
Published: (2019)

Difficult and Severe Asthma in Children
by: Federica Porcaro, et al.
Published: (2020)

Original article Experience in the use of genetically engineered biological drugs for severe bronchial asthma in the Republic of Sakha (Yakutia)
by: Aleksey V. Danilov, et al.
Published: (2024)

Targeting interleukin-4 and interleukin-13 in the treatment of severe eosinophilic asthma
by: Nightingale Syabbalo
Published: (2023)

Benralizumab in the treatment of severe asthma: design, development and potential place in therapy
by: Pelaia C, et al.
Published: (2018)

Tezepelumab as an Emerging Therapeutic Option for the Treatment of Severe Asthma: Evidence to Date
by: Dorey-Stein ZL, et al.
Published: (2021)

Interventions on Adherence to Treatment in Children With Severe Asthma: A Systematic Review
by: Barbara Boutopoulou, et al.
Published: (2018)

Dupilumab in the treatment of severe non-control broncial asthma - economic aspects
by: A. S. Salasyuk, et al.
Published: (2019)

Difficult vs. Severe Asthma: Definition and Limits of Asthma Control in the Pediatric Population
by: Amelia Licari, et al.
Published: (2018)

Registry analysis of patients with severe allergic asthma and clinically relevant sensitization to fungal allergens treated with genetically engineered biologics
by: Daria S. Fomina, et al.
Published: (2022)

A Brief Review of Severe Asthma
by: Muhammad Amin Ibrahim, et al.
Published: (2021)

Severe pediatric asthma therapy: Dupilumab
by: Giuliana Ferrante, et al.
Published: (2022)